Quantitative Systematic Strategies LLC Novo Nordisk A S Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$58.54 - $67.94 $447,421 - $519,265	-7,643 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$49.46 - $64.78 $772,911 - $1.01 Million	-15,627 Reduced 67.16%	7,643 $460,000
Q4 2019 Feb 11, 2020	BUY	$49.86 - $58.26 $1.16 Million - $1.36 Million	23,270 New	23,270 $1.35 Million
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $251,773 - $286,382	-6,061 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $283,412 - $310,565	6,061 New	6,061 $286,000
Q2 2018 Aug 07, 2018	SELL	$44.29 - $50.42 $235,799 - $268,436	-5,324 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$48.49 - $58.14 $258,160 - $309,537	5,324 New	5,324 $262,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.